entertainment -WSS

entertainment

author：knowledge 2025-10-01 21:37:24 - browse：147

A group of four doctors gather around a hologram projecting different medical icons — health tech coverage from STAT — Adobe

DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock valued at over $20 million at the end of Tuesday trading. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.

Founded in 2011, Dario started with a diabetes app targeted at consumers before expanding it to hypertension and weight management. It still maintains that direct-to-consumer business but has since shifted its focus to selling its suite of offerings, including a musculoskeletal care program it acquired in 2021, to health plans and employers in the hopes of reaching much larger patient populations. Recent updates aimed at making itself attractive to clients include a new offering built around popular, and expensive, GLP-1 weight loss drugs, and published real world data suggesting its tools can save clients money on downstream health care costs. With Twill, Dario adds a mental health app and related services, addressing a top demand of employers.

Despite momentum, DarioHealth, which is publicly traded, is unprofitable, and by its own estimations on earnings calls last year, it remained a ways from that milestone. Before acquiring Twill, the company said that it expected the whole business to break even at about $80 million in revenue — about four times the roughly $20 million it projected for 2023. In November, the company reported that it lost over $40 million in the first nine months of 2023.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Involuntary treatment for addiction doesn't work

WSS

Teach medical students about patients with intellectual disabilities

Patients' immediate access to test results puts radiologists in a bind

Pfizer plans to depart BIO

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Eli Lilly to acquire Versanis in heated race for weight loss drugs

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

explore

entertainment

explore

Cancer drug shortages should be causing more outrage

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

DIEP, the 'gold standard' of breast reconstruction, is under threat

What PEPFAR has meant on the ground in Ukraine

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Federal judge rules Oregon’s tough new gun law is constitutional

Sports medicine is finally prioritizing gender equality

Woman gored by Bison at Yellowstone

Drug repurposing or repositioning? The language matters

Mike Pence clashes with Tucker Carlson in Iowa

hotspot

J&J expands global access to TB drug amid advocacy campaign

Involuntary treatment for addiction doesn't work

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

AI models in health care face new federal disclosure requirements

Pregnancy discrimination could be enabled by AI

Congress likely to miss an opportunity to fix drug shortages issue

entertainment

hotspot

knowledge

knowledge